Stocktoria
SERA PROGNOSTICS, INC. SERA
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2021-07-15
SERA PROGNOSTICS, INC. statistics & valuation
Market cap$70.5M
P / B0.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -45066.7% | -47577.9% | -13013.4% | -17034.3% | -43164.6% |
| Net margin | -39417.3% | -42724.7% | -11843.8% | -16487.3% | -42693.9% |
| FCF margin | -32529.6% | -18500.0% | -8926.8% | -13209.3% | -40170.7% |
| Return on assets | -31.3% | -45.3% | -38.0% | -38.0% | -23.8% |
| Return on equity | -42.3% | -68.8% | -51.7% | -44.7% | -25.3% |
| Current ratio | 1.69 | 1.92 | 2.51 | 5.80 | 13.11 |
| Revenue growth | 5.2% | -74.8% | 14.2% | 226.8% | 228.0% |
Source: SEC EDGAR filings · CIK 0001534969 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.